Delivery Order SPE2DB22D3501-SPE2DB24FUP53
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,015.42 to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania. The contract is for the supply of RINVOQ ER 15 MG TABLET with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The company serves as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 45 MG TABLET in quantities of 28. The completion date for this $6,863.94 contract is January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
- The Defense Logistics Agency (DLA) has awarded a $8,241.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division to provide 4564530227 RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense (DoD)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,983.60 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4564110483 RINVOQ ER 30 MG TABLET UU 30S. This order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
- The Defense Logistics Agency (DLA) awarded a $6,360.11 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply RINVOQ ER 30 MG TABLET. The delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,492.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. The contract has a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA Troop Support Medical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,084.60 contract is for the delivery of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, with a performance period through April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $6,863.94 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 45 MG TABLET UU 28S. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 30 MG TABLET UU 30S. The contract has a potential value of $16,973.25 and a performance period through January 29, 2024. Amerisourcebergen Drug Corporation is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUP53Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $10,702.11 to Amerisourcebergen Drug Corp, a for-profit organization, to provide the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have any set-aside designations. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 2/14/24 |